NCT05054803View on ClinicalTrials.gov

Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 13, 2021

Primary Completion Date

January 20, 2024

Study Completion Date

January 20, 2024

Conditions
Spinal Cord Injury Cervical
Interventions
DRUG

WJ-MSC (XCEL-UMC-BETA)

Administration of 2 Intrathecal infusions of WJ-MSC at day 1 and at 3 months

DRUG

Placebo

Administration of 2 Intrathecal infusions of placebo at day 1 and at 3 months

Trial Locations (2)

15006

Complexo Hospitalario Universitario A Coruña (CHUAC), A Coruña

08916

Hospital de Neurorehabilitació Institut Guttmann, Badalona

All Listed Sponsors
collaborator

Institut Guttmann

OTHER

collaborator

Academic Research Organization (ARO) - VHIR

UNKNOWN

collaborator

Complexo Hospitalario Universitario de A Coruña

OTHER

lead

Banc de Sang i Teixits

OTHER

NCT05054803 - Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury | Biotech Hunter | Biotech Hunter